Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
16.93
+0.01 (0.06%)
Bozor ochiq: Aug 12, 2026, 3:08 PM EDT
16.92
0.00 (0.00%)
Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT
Theravance Biopharma, Inc., biotexnologik kompaniya, Qo'shma Shtatlarda dori vositalarini ishlab chiqadi va tijoratlashtiradi. U surunkali obstruktiv o'pka kasalligini (SO'PK) davolash uchun kuniga bir marta qabul qilinadigan, nebulayzer orqali yuboriladigan uzoq muddatli muskarin antagonistlari bo'lgan YUPELRI; va ko'p tizimli atrofiya (MSA) bilan og'rigan bemorlarda simptomatik neyrogen ortostatik gipotenziyani (nOH) davolash uchun 3-faza klinik sinovlarida bo'lgan, kuniga bir marta qabul qilinadigan noradrenalin qayta qabul qilish ingibitori Ampreloxetine ni taklif etadi. U revefenacin, shu jumladan YUPELRI inhalatsion eritmasini ishlab chiqish va tijoratlashtirish bo'yicha Viatris Inc. bilan strategik hamkorlik shartnomasiga ega. Theravance Biopharma, Inc. 2013 yilda ro'yxatga olingan va Janubiy San-Frantsisko, Kaliforniyada joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Aine Miller Ph.D. | Senior VP of Development & Head of Ireland Office |
| Mr. Aziz Sawaf C.F.A. | Senior VP of Operations Strategy & CFO |
| Mr. Brett A. Grimaud Esq. | Senior VP, General Counsel & Secretary |
| Mr. Rick E. Winningham M.B.A. | CEO & Director |
| Mr. Stuart Knight | Senior VP of IT&I and Chief Information Officer |
| Ms. Rhonda F. Farnum | Chief Business Officer and Senior VP of Commercial & Medical Affairs |
| Ms. Stacy L. Pryce | Senior VP & Chief Strategy Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-08-11 | PREM14A | tm2621435-1_prem14a.htm |
| 2026-08-10 | 8-K | tm2622638d1_8k.htm |
| 2026-06-29 | DEFA14A | tm2619064d2_defa14a.htm |
| 2026-06-29 | 8-K | tm2619064d1_8k.htm |
| 2026-06-23 | 8-K | tm2618538d1_8k.htm |
| 2026-06-12 | 8-K | tm2617876d1_8k.htm |
| 2026-05-07 | 8-K | tm2613884d1_8k.htm |
| 2026-05-07 | 10-Q | tbph-20260331x10q.htm |
| 2026-04-28 | DEF 14A | tm261413-1_def14a.htm |
| 2026-03-30 | 8-K | tm2610626d1_8k.htm |